Metforem

Metformin, the active ingredient in Metforem, is a Biguanide presented as an oral dosage form for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus.

GNH USA supplies Metforem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metforem is a Biguanide that acts on glucose metabolism to manage hyperglycaemia. - Type 2 diabetes mellitus: lowers blood glucose by reducing hepatic glucose output and increasing peripheral insulin sensitivity. - Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes through improved insulin action. - Polycystic ovary syndrome (PCOS): assists in correcting insulin resistance associated with the condition.

Metforem may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhoea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe hypoglycaemia: usually when combined with other glucose‑lowering agents. - Vitamin B12 deficiency: may develop with long‑term therapy. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Allergic skin reactions: rash, urticaria, or Stevens‑Johnson syndrome. - Pancreatitis: inflammation of the pancreas, presenting with abdominal pain.

Metforem requires careful patient assessment and monitoring. - Renal function assessment: avoid or adjust dose in patients with impaired renal clearance. - Hepatic function monitoring: use with caution in liver disease. - Blood glucose monitoring: regularly check glucose to avoid hypoglycaemia, especially when combined with insulin. - Contraindicated in metabolic acidosis: do not use in patients with ketoacidosis or severe acidosis. - Use with caution in elderly: increased susceptibility to renal impairment and dehydration. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metforem can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure, increasing risk of lactic acidosis. - Cimetidine: can raise metformin plasma concentrations, heightening toxicity risk. - Alcohol: potentiates lactic acidosis, especially in patients with hepatic disease.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycaemia. - Diuretics (especially thiazides): can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Thyroid hormones: may require adjustment of glycaemic control.